Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets

Whitehurst, 1996, Reversal of acute theophylline toxicity by calcium channel blockers in dog and rates, Toxicology, 110, 113, 10.1016/0300-483X(96)03343-4 Lordi, 1986, Sustained release dosage forms, 430 Williams, 1983, Relative bioavailability of two sustained-release theophylline formulations versus an immediate–release preparation, J. Asthma, 20, 27, 10.3109/02770908309070908 Buckton, 1988, In vitro dissolution of some commercially available sustained-release theophylline preparations, Int. J. Pharm., 42, 35, 10.1016/0378-5173(88)90157-3 Sallans, 1988, Etude comparative de cinq specialités de théophylline à libèration prolongée, J. Pharm. Belg., 43, 81 Shangraw, 1988, Design and formulation of sustained release theophylline dosage forms, Drug Dev. Ind. Pharm., 14, 319, 10.3109/03639048809151973 Munday, 1995, In vitro–in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-dur tablets, Int. J. Pharm., 118, 251, 10.1016/0378-5173(94)00391-H Rodriguez, 1993, In vitro release of theophylline from directly-compressed matrices containing methacrylic acid copolymers and/or dicalcium phosphate dihydrate, Farmaco, 48, 1597 Sriamorsnak, 1997, Development of sustained release theophylline pellets coated with calcium pectinate, J. Control. Rel., 47, 221, 10.1016/S0168-3659(97)01640-4 Neau, 1999, The effect of the aqueous solubility of xanthine derivatives on the mechanism of release from ethylcellulose matrix tablets, Int. J. Pharm., 179, 97, 10.1016/S0378-5173(98)00391-3 Alvarez-Lorenzo, 2000, The stability of theophylline tablets with a hydroxypropylcellulose matrix, Drug Dev. Ind. Pharm., 26, 13, 10.1081/DDC-100100322 Rey, 2000, Development of matrix-based theophylline sustained release microtablets, Drug Dev. Ind. Pharm., 26, 21, 10.1081/DDC-100100323 Aiedeh, 2001, Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads, Eur. J. Pharm. Sci., 13, 159, 10.1016/S0928-0987(00)00217-7 Muskó, 2001, Study of in vitro and in vivo dissolution of theophylline from film-coated pellets, Eur. J. Pharm. Biopharm., 51, 143, 10.1016/S0939-6411(00)00147-8 Ferrero, 1997, Drug release from a new family of graft copolymers of methyl-methacrylate, Int. J. Pharm., 149, 233, 10.1016/S0378-5173(97)04874-6 Pather Russell, 1998, Sustained-release theophylline tablets by direct compression, Part I: formulation and in vitro testing, 164, 1 Khan, 1975, The concept of dissolution efficiency, J. Pharm. Pharmacol., 27, 48, 10.1111/j.2042-7158.1975.tb09378.x